Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity

Objectives To compare serum levels of the receptor for advanced glycation end products (sRAGE) between multiple sclerosis (MS) patients and healthy control subjects, and to investigate whether serum sRAGE levels correlate with MS disease severity as indicated by the Kurtzke Expanded Disability Statu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2008-07, Vol.14 (6), p.759-763
Hauptverfasser:	Sternberg, Z, Weinstock-Guttman, B, Hojnacki, D, Zamboni, P, Zivadinov, R, Chadha, K, Lieberman, A, Kazim, L, Drake, A, Rocco, P, Grazioli, E, Munschauer, F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Biomarkers - blood Cross-Sectional Studies Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Disability Evaluation Enzyme-Linked Immunosorbent Assay Female Humans Male Medical sciences Middle Aged Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Multiple Sclerosis, Chronic Progressive - blood Multiple Sclerosis, Chronic Progressive - immunology Multiple Sclerosis, Relapsing-Remitting - blood Multiple Sclerosis, Relapsing-Remitting - immunology Neurology Receptor for Advanced Glycation End Products Receptors, Immunologic - blood Severity of Illness Index Solubility
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!